Free Access
Issue
J Extra Corpor Technol
Volume 52, Number 1, March 2020
Page(s) 13 - 21
DOI https://doi.org/10.1051/ject/202052013
Published online 15 March 2020
  1. Stewart GC, Givertz MM Mechanical circulatory support for advanced heart failure: Patients and technology in evolution. Circulation. 2012;125:1304–15. [CrossRef] [PubMed] [Google Scholar]
  2. Susen S, Rauch A, Van Belle E, et al. Circulatory support devices: Fundamental aspects and clinical management of bleeding and thrombosis. J Thromb Haemostasis. 2015;10:1757–67. [CrossRef] [Google Scholar]
  3. Nielsen VG, Kirklin JK, Holman WL, et al. Mechanical circulatory device thrombosis: A new paradigm linking hypercoagulation and hypofibrinolysis. Am Soc Artif Intern Organs J. 2008;54:351–8. [CrossRef] [PubMed] [Google Scholar]
  4. Levy JH, Tanaka KA Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg. 2003;75:S715–720. [CrossRef] [PubMed] [Google Scholar]
  5. Thompson LO, Loebe M, Noon GP What price support? Ventricular assist device induced systemic response. Am Soc Artif Intern Organs J. 2003;49:518–26. [CrossRef] [PubMed] [Google Scholar]
  6. John R, Lee S The biological basis of thrombosis and bleeding in patients with ventricular assist devices. J Cardiovasc Transl Res. 2009;2:63–70. [CrossRef] [PubMed] [Google Scholar]
  7. Suarez J, Patel CB, Felker GM, et al. Mechanisms of bleeding and approach to patients with axial-flow left ventricular assist devices. Circ Heart Fail. 2011;4:779–84. [CrossRef] [PubMed] [Google Scholar]
  8. Crow S, Chen D, Milano C, et al. Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients. Ann Thorac Surg. 2010;90:1263–9. [CrossRef] [PubMed] [Google Scholar]
  9. Crow S, John R, Boyle A, et al. Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices. J Thorac Cardiovasc Surg. 2009;137:208–15. [CrossRef] [PubMed] [Google Scholar]
  10. Reich HJ, Morgan J, Arabia F, et al. Comparative analysis of von Willebrand factor profiles after implantation of left ventricular assist device and total artificial heart. J Thromb Haemostasis. 2017;15:1620–4. [CrossRef] [Google Scholar]
  11. Heilmann C, Geisen U, Benk C, et al. Haemolysis in patients with ventricular assist devices: Major differences between systems. Eur J Cardiothorac Surg. 2009;36:580–4. [CrossRef] [PubMed] [Google Scholar]
  12. Hoffman M, Monroe DM3rd A cell-based model of hemostasis. Thromb Haemostasis. 2001;85:958–65. [CrossRef] [PubMed] [Google Scholar]
  13. Yang Z, Xie Z, Pei X, et al. Effect of thrombelastography on timing of coronary artery bypass grafting. Exp Ther Med. 2018;16:579–84. [PubMed] [Google Scholar]
  14. Mahla E, Suarez TA, Bliden KP, et al. Platelet function measurement-based strategy to reduce bleeding and waiting time in clopidogrel-treated patients undergoing coronary artery bypass graft surgery: The timing based on platelet function strategy to reduce clopidogrel-associated bleeding related to CABG(TARGET-CABG) study. Circ Cardiovasc Interv. 2012;5:261–9. [CrossRef] [PubMed] [Google Scholar]
  15. Bochsen L, Wiinberg B, Kjelgaard-Hansen M, et al. Evaluation of the TEG® platelet mapping TM assay in blood donors. Thromb J. 2007;5:3. [CrossRef] [PubMed] [Google Scholar]
  16. Volod O, Lam LD, Lin G, et al. Role of thromboelastography platelet mapping and international normalized ratio in defining “normocoagulability” during anticoagulation for mechanical circulatory support devices: A pilot retrospective study. Am Soc Artif Intern Organs J. 2017;63:24–31. [CrossRef] [PubMed] [Google Scholar]
  17. Karon BS, Tolan NV, Koch CD, et al. Precision and reliability of 5 platelet function tests in healthy volunteers and donors on daily antiplatelet agent therapy. Clin Chem. 2014;60:1524–31. [CrossRef] [PubMed] [Google Scholar]
  18. Craft RM, Chavez JJ, Bresee SJ, et al. A novel modification of the thrombelastograph assay, isolating platelet function, correlates with optical platelet aggregation. J Lab Clin Med. 2004;143:301–9. [CrossRef] [PubMed] [Google Scholar]
  19. Bolliger D, Seeberger MD, Tanaka KA Principles and practice of thromboelastography in clinical coagulation management and transfusion practice. Transfus Med Rev. 2012;26:1–13. [CrossRef] [PubMed] [Google Scholar]
  20. Haemonetics Corporation. Customer letter CL101323, 2015. [Google Scholar]
  21. Nelles NJ, Chandler WL Platelet mapping assay interference due to platelet activation in heparinized samples. Am J Clin Pathol. 2014;142:331–8. [CrossRef] [PubMed] [Google Scholar]
  22. Giorni C, Costopoulos M, Bachelot-Loza C, et al. Platelet-mapping assay for monitoring antiplatelet therapy during mechanical circulatory support in children: A retrospective observational study. Res Pract Thromb Haemost. 2017;1:120–7. [CrossRef] [PubMed] [Google Scholar]
  23. Almond CS, Buchholz H, Massicotte P, et al. Berlin heart EXCOR pediatric ventricular assist device investigational device exemption study: study design and rationale. Am Heart J. 2011;162:425–35. [CrossRef] [PubMed] [Google Scholar]
  24. Manoharan A, Gemmell R, Hartwell T Use of whole blood platelet lumi-aggregometry to optimize anti-platelet therapy in patients with chronic myeloproliferative disorders. Am J Hematol. 2006;81:676–83. [CrossRef] [PubMed] [Google Scholar]
  25. Israels SJ, Robertson C, McNicol A Identification of patients with storage pool deficiency using ATP release and dense granule counts. Hematology. 1997;2:161–7. [CrossRef] [PubMed] [Google Scholar]
  26. Kweon OJ, Lim YK, Kim B, et al. Effectiveness of platelet function analyzer-100 for laboratory detection of anti-platelet drug-induced platelet dysfunction. Ann Lab Med. 2018;39:23–30. [Google Scholar]
  27. Bartels A, Sarpong Y, Coberly J, et al. Failure of the platelet function assay (PFA)-100 to detect antiplatelet agents. Surgery. 2015;158:1012–8. [CrossRef] [PubMed] [Google Scholar]
  28. Volod O, Lam LD, Mirocha J, et al. , TEG platelet mapping (TEG PM) guided management of patients with total artificial heart (TAH): A single center 5-year experience. Artif Organs. 2018;42:A26. [Google Scholar]
  29. Potapov EV, Antonides C, Crespo-Leiro MG, et al. 2019 EACTS expert consensus on long-term mechanical circulatory support. Eur J Cardio Thorac Surg. 2019;56:230–70. [CrossRef] [PubMed] [Google Scholar]
  30. Chandler WL, Brown AF, Chen D, et al. External quality assurance of platelet function assays: Results of the college of American pathologists proficiency testing program. Arch Pathol Lab Med. 2019;143:472–82. [CrossRef] [PubMed] [Google Scholar]
  31. Ferguson LP, Duong P, Pearce KF, et al. Monitoring of antiplatelet therapy in children on ventricular assist device support: Comparison of multiplate and thromboelastography platelet mapping. Am Soc Artif Intern Organs J. 2019;65:84–93. [CrossRef] [PubMed] [Google Scholar]
  32. Sivapalan P, Bäck AC, Ostrowski SR, et al. Transfusion requirements in elective cardiopulmonary bypass surgery patients: Predictive value of multiplate and thromboelastography (TEG) platelet mapping assay. Scand J Clin Lab Invest. 2017;77:345–51. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.